Bluejay Diagnostics, Inc. financial data

Symbol
BJDX on Nasdaq
Location
Acton, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 06 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 370% % -16%
Debt-to-equity 26% % 6.5%
Return On Equity -146% % -17%
Return On Assets -116% % -16%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 972,215 shares 75%
Common Stock, Shares, Outstanding 604,534 shares 336%
Entity Public Float $2,570,000 USD 51%
Common Stock, Value, Issued $60 USD 329%
Weighted Average Number of Shares Outstanding, Basic 449,043 shares 879%
Weighted Average Number of Shares Outstanding, Diluted 449,043 shares 879%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $3,046,448 USD -12%
Selling and Marketing Expense $8,297 USD
General and Administrative Expense $3,906,524 USD 5.9%
Operating Income (Loss) $6,952,972 USD 3%
Nonoperating Income (Expense) $104,489 USD -39%
Net Income (Loss) Attributable to Parent $6,848,483 USD 11%
Earnings Per Share, Basic -15.25 USD/shares 97%
Earnings Per Share, Diluted -15.25 USD/shares 97%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,164,875 USD 20%
Assets, Current $5,463,602 USD 12%
Property, Plant and Equipment, Net $1,534,441 USD 1.4%
Operating Lease, Right-of-Use Asset $113,289 USD -46%
Other Assets, Noncurrent $7,905 USD -78%
Assets $7,119,237 USD 6.9%
Accounts Payable, Current $214,255 USD 48%
Accrued Liabilities, Current $804,942 USD 46%
Liabilities, Current $1,119,197 USD 38%
Operating Lease, Liability, Noncurrent $20,211 USD -81%
Other Liabilities, Noncurrent $4,540 USD -47%
Liabilities $1,143,948 USD 23%
Retained Earnings (Accumulated Deficit) $41,517,267 USD -20%
Stockholders' Equity Attributable to Parent $5,975,289 USD 4.3%
Liabilities and Equity $7,119,237 USD 6.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,184,857 USD 48%
Net Cash Provided by (Used in) Financing Activities $985,000 USD -135%
Net Cash Provided by (Used in) Investing Activities $35,433 USD 90%
Common Stock, Shares Authorized 250,000,000 shares 0%
Common Stock, Shares, Issued 604,534 shares 336%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5,164,875 USD 20%
Deferred Tax Assets, Valuation Allowance $12,089,606 USD 20%
Deferred Tax Assets, Gross $12,089,606 USD 20%
Operating Lease, Liability $120,211 USD -46%
Depreciation $18,401 USD -6.7%
Payments to Acquire Property, Plant, and Equipment $35,433 USD -90%
Lessee, Operating Lease, Liability, to be Paid $125,000 USD -48%
Property, Plant and Equipment, Gross $1,679,058 USD -1.7%
Operating Lease, Liability, Current $100,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $25,000 USD -75%
Lessee, Operating Lease, Liability, to be Paid, Year One $100,000 USD -12%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,789 USD -70%
Lessee, Operating Lease, Liability, to be Paid, Year Three $25,000 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards $8,696,586 USD 37%
Operating Lease, Payments $38,259 USD -13%
Share-based Payment Arrangement, Expense $2,650 USD -137%
Interest Expense $185,893 USD